Anne Gregor

Has grant

Senior Researcher

University Hospital of Bern
Country flagSwitzerland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Modelling LHX2-associated neurodevelopmental disorder in human brain organoids

Open Date: 2022-01-01

Close Date: 2023-06-01

Grant: Close

The role of protein degradation in FBXO11-related intellectual disability (Degradation_ID)

Open Date: 2019-07-01

Close Date: 2021-07-01

Grant: Close

Characterizing the role of FBXO11 and ubiquitination and proteasomal degradation in intellectual disability

Open Date: 2018-12-01

Close Date: 2019-11-01

Grant: Close

Elucidation of the pathogenesis of Dandy-Walker malformation

Open Date: 2015-01-01

Close Date: 2017-12-31

Articles (14)

Serine/arginine repetitive matrix protein 1 (SRRM1) is a key component of spliceosomes and plays various roles in messenger RNA processing. To date, its function in the nervous system has not been elucidated, and germline variants in SRRM1 have not yet been implicated in disease. Through international collaboration, we have identified three individuals harbouring heterozygous truncating variants in SRRM1 , presenting variably with developmental delay, intellectual disability, short stature, behavioural and skeletal anomalies, and facial dysmorphism. Two of the variants occurred de novo, while the third could not be tested in the parents. Reduction of SRRM1 to 50% in SKNBE2 cells by introducing a truncating variant via CRISPR-Cas9 editing, followed by differentiation into neuron-like cells, resulted in impaired cell proliferation, migration, and neurite outgrowth compared to wild-type cells. Additionally, the role of SRRM1 in nervous system development and functioning was investigated in vivo using a Drosophila model. Pan-neuronal knockdown of the orthologue Srrm1 led to reduced viability, while motoneuronal knockdown impaired gross neurological function. Taken together, we provide multiple lines of evidence that loss of SRRM1 is associated with nervous system-related phenotypes, and that its haploinsufficiency may be causative for a neurodevelopmental disorder.

Year:

2026

Year:

2026

While mostly de novo truncating variants in SCAF4 were recently identified in 18 individuals with variable neurodevelopmental phenotypes, knowledge on the molecular and clinical spectrum is still limited. We assembled data on 50 novel individuals with SCAF4 variants ascertained via GeneMatcher and personal communication. With detailed evaluation of clinical data, in silico predictions and structural modeling, we further characterized the molecular and clinical spectrum of the autosomal dominant SCAF4 -associated neurodevelopmental disorder. The molecular spectrum comprises 25 truncating, eight splice-site and five missense variants. While all other truncating variants were classified as pathogenic/likely pathogenic, significance of one C-terminal truncating variant, one splice-site variant and the missense variants remained unclear. Three missense variants in the CTD-interacting domain of SCAF4 were predicted to destabilize the domain. Twenty-three variants occurred de novo, and variants were inherited in 13 cases. Frequent clinical findings were mild developmental delay with speech impairment, seizures, and skeletal abnormalities such as clubfoot, scoliosis or hip dysplasia. Cognitive abilities ranged from normal IQ to severe intellectual disability (ID), with borderline to mild ID in the majority of individuals. Our study confirms the role of SCAF4 variants in neurodevelopmental disorders and further delineates the associated clinical phenotype.

Year:

2025

While de novo missense variants in the BTB domains of atypical RhoGTPase RHOBTB2 cause a severe developmental and epileptic encephalopathy, de novo missense variants in the GTPase domain or bi-allelic truncating variants are associated with more variable neurodevelopmental and seizure phenotypes. Apart from the observation of RHOBTB2 abundance resulting from BTB-domain variants and increased seizure susceptibility in Drosophila overexpressing RhoBTB, our knowledge on RHOBTB2-related pathomechanisms is limited. We now found enrichment for ion channels among the differentially expressed genes from RNA-Seq on fly heads overexpressing RhoBTB. Subsequent genetic interaction experiments confirmed a functional link between RhoBTB and paralytic, the orthologue of human sodium channels, including epilepsy associated SCN1A, in vivo. We then performed patch-clamp recordings on mature neurons differentiated from human induced pluripotent stem cells with either homozygous frameshifts or patient-specific heterozygous missense variants in the GTPase or the BTB domains. This revealed significantly altered neuronal activity and excitability resulting from BTB domain variants but not from GTPase domain variants or upon complete loss of RHOBTB2. Our study indicates a role of deregulated ion channels in the pathogenesis of RHOBTB2-related developmental and epileptic encephalopathy and points to specific pathomechanisms underlying the observed genotype–phenotype correlations regarding variant zygosity, location and nature.

Year:

2025

Year:

2025

Year:

2025

The dyskerin encoding gene DKC1 plays an important role in telomerase activity and telomere maintenance. Pathogenic variants in DKC1 cause an X‐linked multiorgan disease called dyskeratosis congenita (DC), the most severe form of which is Hoyeraal–Hreidarsson syndrome (HHS). HHS due to DKC1 variants has so far only been reported in hemizygous males and is associated with severe neurological impairment and progressive bone marrow failure, often causing lethality in early childhood. Heterozygous carrier females are often phenotypically normal. Here, we report a young adult female carrying a de novo splice‐site variant in DKC1 and presenting with clinical features overlapping with HHS, such as intrauterine and postnatal growth retardation, microcephaly, intellectual disability, and recurrent infections, while lacking other typical aspects such as dermatological manifestations, cerebellar hypoplasia, or bone marrow failure. Aberrant splicing was confirmed with an in vitro assay, and further analysis revealed very short telomere lengths in the individual, supporting a causative role of the DKC1 variant. Our observations therefore suggest that heterozygous splice‐site variants in DKC1 leading to loss of function might result in a phenotype overlapping with but not being typical for HHS in females, supporting a potential genotype–phenotype correlation.

Year:

2025

Two Jack-Russell Terrier × Chihuahua mixed-breed littermates with Leigh syndrome were investigated. The dogs presented with progressive ataxia, dystonia, and increased lactate levels. Brain MRI showed characteristic bilateral symmetrical T2 hyperintense lesions, histologically representing encephalomalacia. Muscle histopathology revealed accumulation of mitochondria. Whole genome sequencing identified a missense variant in a gene associated with human Leigh syndrome, NDUFS7 :c.535G > A or p.(Val179Met). The genotypes at the variant co-segregated with the phenotype in the investigated litter as expected for a monogenic autosomal recessive mode of inheritance. We investigated the functional consequences of the missense variant in a Drosophila melanogaster model by expressing recombinant wildtype or mutant canine NDUFS7 in a ubiquitous knockdown model of the fly ortholog ND-20. Neither of the investigated overexpression lines completely rescued the lethality upon knockdown of the endogenous ND-20. However, a partial rescue was found upon overexpression of wildtype NDUFS7, where pupal lethality was moved to later developmental stages, which was not seen upon canine mutant overexpression, thus providing additional evidence for the pathogenicity of the identified variant. Our results show the potential of the fruit fly as a model for canine disease allele validation and establish NDUFS7 :p.(Val179Met) as causative variant for the investigated canine Leigh syndrome .

Year:

2024

Year:

2024

In this review we describe different model organisms and systems that are commonly used to study syndromic disorders. Different use cases in modeling diseases, underlying pathomechanisms and specific effects of certain variants are elucidated. We also highlight advantages and limitations of different systems. Models discussed include budding yeast, the nematode worm, the fruit fly, the frog, zebrafish, mice and human cell-based systems.

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (18)

Sangmoon Lee

University of California, San Diego

UNITED STATES
View details

Gabriele Siegel

University of Zurich

SWITZERLAND
View details

Anna Ruiz

Institute of Research and Innovation Parc Tauli

SPAIN
View details

Christiane Zweier

Head

Inselspital Universitätsspital Bern

SWITZERLAND
View details

Annemieke Aartsma-Rus

Professor of Translational Genetics

Leiden University Medical Center

NETHERLANDS
View details

Mina Ryten

University College London

UNITED KINGDOM
View details

Julian Martinez-Agosto

Associate Professor (with tenure)

David Geffen School of Medicine at UCLA

UNITED STATES
View details

Amica Müller-Nedebock

Staff Scientist

University Hospital Leipzig

GERMANY
View details

Timothy Yu

Associate Member

Broad Institute

UNITED STATES
View details

Alice Davidson

Professor of Molecular Genetics

University College London

UNITED KINGDOM
View details

Maya Chopra

Director of Translational Genomic Medicine

Boston Children's Hospital

UNITED STATES
View details

Matthis Synofzik

Professor

Hertie Institute for clinical brain research

GERMANY
View details

Thomas Nevian

University of Bern

SWITZERLAND
View details

Kristen Deak

Assistant Professor

Duke University

UNITED STATES
View details

Gregory Costain

Hospital for Sick Children

CANADA
View details

Stephan Sanders

Professor of Paediatric Neurogenetics

University of Oxford

UNITED KINGDOM
View details

Robert Harvey

Associate Dean, Research, School of Health

University of the Sunshine Coast

AUSTRALIA
View details

Hormos Salimi Dafsari

Max Planck Institute for Biology of Ageing

GERMANY
View details